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Abstract
Background: Proliferative vitreoretinopathy (PVR) is a known complication of retinal detachment surgery. It has
been postulated that the establishment of PVR involves inflammatory and ischaemic processes. Surgical and clinical
risk factors contribute to making certain patients more vulnerable to developing PVR.
The objective of this systematic review is to identify and appraise the evidence on clinical and surgical risk factors
and their utility in predicting the occurrence or worsening of PVR post-surgery.
Methods: Electronic databases and grey literature will be searched dating from 1980. Studies will be eligible if they
include patients that underwent retinal reattachment surgery for rhegmatogenous retinal detachment (RRD), with
and without PVR, and where risk factors were measured before or during surgery. Screening, data extraction and
quality assessment will be performed independently by two reviewers using pre-defined criteria. Should any models be
identified, we will liaise with the Cochrane prognostic group to help define the most appropriate quality assessment
criteria based on the PROBLAST tool which is in development. All findings will be tabulated and narratively synthesised.
Studies presenting models or adjusted data will likely be more informative than studies reporting unadjusted results for
a single risk factor. When clinically and methodologically appropriate, random effects meta-analysis will be performed.
Discussion: This review will systematically and comprehensively retrieve evidence to evaluate the clinical and surgical
risk factors associated with PVR. The identified evidence may aid standardisation of clinical practice and more effective
management for improving patient outcomes following RRD surgery and will provide a clear reference point for
vitreoretinal surgeons.
Systematic review registration: PROSPERO CRD42016035848
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Background
Proliferative vitreoretinopathy (PVR) occurs in 5–10 %
rhegmatogenous retinal detachment (RRD) cases and is
the main cause of surgical failure [1]. PVR occurs in a
series of phases starting from the moment a retinal tear
occurs and ending by apoptosis and contraction of mem-
branes. Tissue fibrosis is characterised by the accumula-
tion of an excessive number of fibroblasts followed by the
unregulated deposition of collagen and other matrix
components. The constant exposure to growth factors
and cytokines causes cells to produce excessive extra-
cellular matrix (ECM) components. A major component
of PVR generation is from an exaggerated inflammatory
reaction to retinal tears and detachment [2]. Retinal pig-
ment epithelial (RPE) cells are released through retinal
breaks and migrate along the retinal surface. RPE cells go
through the epithelial-mesenchymal transition to form
fibroblast-like cells that significantly contribute to scar
formation by ECM production in the retina and therefore
PVR. The unbalanced action of growth factors and cyto-
kines is thought to be a causative element of fibrosis.
Classification of PVR in clinical practice and preclinical
research is based on the ophthalmoscopic appearance, the
subjective evaluation of the amount of membrane con-
traction and its distribution [3]. The classification is not
related to the evolution of PVR. PVR becomes clinically
significant if it predisposes a RD case to surgical failure,
causing a re-detachment or limiting visual recovery post-
operatively.
Considering the pathobiology of PVR, the majority of
clinical factors associated with an accentuated healing
response sufficient to cause PVR appear to include an
inflammatory component or a release of RPE cells into
the vitreous. Several studies have focused on the identifi-
cation of a large number of overlapping risk factors and
associations for the development of PVR, some of which
are more consistent than others with the known under-
lying pathophysiology. These encompass the presence of
a posterior vitreous detachment; longer RD duration;
greater physical extent of the detachment; associated
vitreous haemorrhage; clinical signs of intraocular inflam-
mation; a history of previous retinal or lens surgery; and
increased retinal tear size, especially giant retinal tears. In
cases of RRD presenting with pre-existing PVR [4–7],
there is a significant risk of progression to further ad-
vanced PVR. Surgical factors associated with PVR devel-
opment included extensive cryopexy and laser retinopexy,
failure to close retinal breaks, peri-operative scleral perfor-
ation and peri-operative vitreous haemorrhage [5, 8, 9].
This information can be used in surgical planning so that
manoeuvres that risk intraocular haemorrhage or increase
post-operative inflammation are avoided. Examples of fac-
tors to consider would include the following: method of
retinopexy; type of tamponade and timing of surgery.
Other associated factors included previous crystalline lens
removal resulting in aphakia [10] or pseudophakia, the use
of intravitreal air, the use of vitrectomy and a greater
number of operations required to flatten the retina.
A scoping search on Medical Literature Analysis and
Retrieval System Online (MEDLINE) found no existing
systematic reviews looking at clinical and surgical risk
factors. The aim of this systematic review is to identify
and appraise the evidence on the prognostic utility of
clinical and surgical risk factors in predicting the occur-
rence of PVR.
Specific objectives are to identify whether development
or worsening of PVR is associated with:
 Pre-existing PVR
 Extent of retinal detachment
 Vitreous haemorrhage
 Retinopexy
 Large retinal break
 Lens status
 Surgical factors
To ensure rigour, the protocol for this systematic re-
view has been guided by the Preferred Reporting Items
for Systematic Reviews and Meta-Analysis Protocols
(PRISMA-P) checklist (Additional file 1). The protocol
has been registered on PROSPERO (CRD42016035848).
Methods
Study criteria
Type
Any studies are included where the prognostic factor is
measured in advance of the outcome. A retrospectively
identified cohort where the risk factors were measured
prior to or at surgery would be suitable for inclusion.
Studies are eligible if they include patients that underwent
retinal reattachment surgery for RRD, with and without
PVR. Studies reporting any prognostic models including
relevant risk factors will also be included. Abstracts will be
included.
Participants
In all included studies, the population will consist of a
cohort of patients that underwent retinal reattachment
surgery for RRD and were followed up to determine
whether PVR developed post-operatively or whether
established PVR worsened. The two groups will be ana-
lysed separately. Surgery will include scleral buckling,
pars plana vitrectomy and other related intra-operative
procedures required for reattachment.
Risk factors
Studies have to report of at least one of the following:
clinical risk factors, surgical risk factors or prediction
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model for developing PVR after retinal reattachment
surgery. Studies are eligible if risk factors were recorded
using clinical information collected before and during
the surgical intervention.
The existence of pre-operative or established PVR
suggests that the cellular, extracellular and chemical ele-
ments required for wound healing are present in a pro-
inflammatory ‘soup’. A total protein level represents the
sum of all detectable proteinaceous components in the vit-
reous. It provides information on the state of inflamma-
tion, breakdown of blood-retinal barrier (BRB) and the
severity of wound healing.
Detachments extending over two quadrants (six clock
hours) are more likely to develop PVR [6]. It has been
suggested that a larger detachment is associated with a
greater disruption of the BRB through ischaemic injury
resulting in a greater influx of serum components into
the vitreous cavity [6]. Larger detachments are associ-
ated with PVR, supporting earlier scheduling of smaller
macula-off RDs for surgery, to minimise the spread of
the detachment and the risk of PVR [11]. Furthermore,
disruption of the BRB is exacerbated by the requirement
of extensive surgery for the management of large RDs.
Intraocular haemorrhage is an overt sign of BRB fail-
ure with direct leakage of fibrin and pro-inflammatory
growth factors into the eye. Any form of intraocular
haemorrhage occurring pre-operatively, peri-operatively
or post-operatively was associated with the generation of
PVR. The association of vitreous haemorrhage with PVR
could be due to the release of serum elements creating a
rich pro-fibrotic environment [12].
Cryotherapy increases blood aqueous breakdown from
the associated chorioretinal trauma, as well as promoting
RPE migration. Cryotherapy causes a release of RPE cells
throughout the ocular fluid, due to alteration in the
protein matrix on electron microscopy [13, 14].
Eyes with horseshoe tears are more likely to develop
PVR than those with atrophic holes [15]. Cryotherapy has
been found to be a stimulating factor for post-operative
PVR in RDs due to horseshoe tears with curled posterior
edges or retinal tears 180° and over [16].
It has been suggested that the posterior lens capsule
may protect the anterior uvea, the site of active transport,
from mechanical and physical irritation by the vitreous gel
in phakic eyes [10]. It is possible that the intact lens
provides a physical barrier for transmission of inflamma-
tory cytokines from the anterior chamber to the vitreous
cavity.
Outcome measure
The development of post-operative PVR or worsening of
existing PVR is based on clinical biomicroscopy and
surgical outcomes. PVR will be defined as recurrent or
persistent RD, tractional RD or a combination of tractional
RRD. Pre-existing PVR will be defined as those partici-
pants that have PVR prior to initial surgery (refer to
Additional file 2).
Identification of studies
Databases
The following electronic databases will be searched:
MEDLINE, MEDLINE In-Process, Cochrane Library,
Excerpta Medica dataBASE (EMBASE) and Biosciences
Information Service (BIOSIS) Citation Index. Search strat-
egies will be adapted for individual databases. A sample
strategy is shown in Additional file 3.
Searches for relevant literature on these databases will
be done using a combination of free text and index terms
related to ‘proliferative vitreoretinopathy’ and ‘tractional
retinal detachment’, combined with terms related to risk
factors, prediction and prognosis.
Searches will be restricted to human studies but without
applying restrictions on language, publication type or date.
Reference lists of included studies will be checked, and a
citation search will be carried out to locate further articles
citing the included studies.
Grey literature
Electronic Theses Online Service (EthOS) and conference
abstract databases (Zetoc (British Library) and Conference
Proceedings Citation Index (Web of Science)) will be
searched electronically. Contact with experts will help find
resources and reports that may not have been identified
through routine searches of databases. In addition, searches
of clinical trial registers such as UK Clinical Research
Network (UKCRN) and UK Clinical Trials Gateway will
be conducted. Main trial databases will be searched for
any relevant ongoing studies (clinicaltrials.gov) [17].
After deletion of duplicates, titles and abstracts of the
records retrieved from electronic databases will be screened
to eliminate clearly irrelevant studies. Full-text articles
will be obtained for the remaining records (i.e. those
considered potentially relevant and those with unclear
relevance requiring clarification) and assessed for eligi-
bility based on the inclusion and exclusion criteria.
Screening of studies will be performed independently
by two reviewers. Any differences in opinions will be
resolved through discussion until a consensus is
reached. If necessary, a third person may be consulted.
Reference management software will be used to facili-
tate the screening process and a PRISMA flow diagram
used for documentation.
Data extraction and coding
The following data will be collected from included stud-
ies using a standardised data extraction form:
 Details on study design
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 Eligibility criteria for study participation and/or
selection of study sample
 Exclusion criteria for the study
 Patient characteristics and features of retinal
detachments
 Method of retinal reattachment surgery and related
procedures
 Clinical risk factors investigated and method of
detection/quantification
 Ascertainment of post-surgical PVR and length of
follow-up
 Methods of analysis, including statistical tests and
methods of variable selection, resultant regression
equations and adjusted versus unadjusted results
Data extraction forms will be piloted on a sample of
included studies to ensure that all the relevant informa-
tion is captured and that resources are not wasted on
extracting data that is not required. A second reviewer
will check the data.
Quality assessment
Two review authors will independently assess the risk of
bias of the included studies using the Quality in Prog-
nostic Studies (QUIPS) tool [18]. Important areas that
will be considered when evaluating validity and bias in
studies of prognostic factors include the following: partici-
pation, attrition, prognostic factor measurement, confound-
ing measurement and account, outcome measurement and
analysis and reporting. The quality assessment tool will be
tailored to the review and piloted on a small selection of in-
cluded studies. Quality assessment of studies may involve a
degree of subjective judgement, and any differences in
opinion will be resolved through discussion. Should any
studies describing models be identified, the Probast steering
group [19] will be contacted for the latest version of the (as
yet unpublished) assessment tool.
Data analysis and synthesis
Study findings will be tabulated and narratively summarised.
Results will be grouped according to different clinical
or surgical risk factors. The main summary outcome
measure will be the relative risk of developing (or worsen-
ing of) PVR in the presence or absence of one or more
surgical or clinical risk factor(s).
We will use thresholds for ordering of prognostic fac-
tor data as presented by the authors. If authors use more
than one, results for all will be presented as statistical
significance and direction of effect may depend on the
threshold. Where findings are presented using a prognostic
factor on a continuous scale, it may be possible to dichot-
omise using thresholds. A retinal detachment extending
over two quadrants (six clock hours) would constitute as
an extensive detachment. A large retinal break would be
classed as greater than 1 disc diameter in size or a giant
retinal tear (greater than three clock hours).
Assessment of clinical and methodological heterogen-
eity will determine the feasibility of meta-analysis. The
main sources of heterogeneity are likely to be the type
and timing of surgery. Where meta-analysis is consid-
ered feasible, random effects model is more likely to be
appropriate given that there is likely to be between-study
heterogeneity. Separate meta-analyses will be conducted
for adjusted and unadjusted data and for different study
designs. Statistical heterogeneity will be assessed using
the χ2 test and the I2 statistic. Where sufficient data is
available, the possibility of sub-group analysis will be
considered. The main subgroups will relate to participant
type, method of surgery (scleral buckling or vitrectomy
surgery), timing of surgery and development or worsening
of PVR.
Assessment of publication bias using funnel plots will
be considered if there are sufficient studies (>10) in indi-
vidual meta-analyses.
Where it is not appropriate to perform meta-analysis,
included studies will be combined in a narrative synthesis,
and where possible, the results of the included studies will
be presented in a forest plot without a pooled estimate.
If a large number of relevant studies are identified, then a
step-wise approach to analysis may be used, with studies
reporting prognostic models and adjusted results likely to be
more informative than studies reporting on a single prog-
nostic factor or unadjusted results only. Scoping searches
have found that there are unlikely to be any models.
The main study characteristics of any relevant ongoing
research identified will be tabulated.
Reporting
The review and its findings will be reported in accord-
ance to the PRISMA guidelines. The findings will be dis-
cussed in the context of the strengths and weaknesses of
both the review methods and the available evidence.
This will include a discussion of the likely impact of any
ongoing research on the review findings. The generalisabil-
ity and implications of the review findings will be discussed
in the context of the current and future clinical practice
for the prevention of PVR.
Discussion
Combined assessment of clinical and surgical risk factors
may aid in better prediction of PVR risk following RD
surgery. Awareness of these factors in the development
of PVR may allow for a more careful planning of surgery
to minimise risk. Pathways involved in the development
of PVR could provide insight into future treatment
targets.
This review will systematically and comprehensively
retrieve evidence from a wide range of sources to
Chaudhary et al. Systematic Reviews  (2016) 5:107 Page 4 of 5
identify evidence on clinical and surgical risk factors
associated with PVR.
It is hoped that this review will provide a clear refer-
ence point for vitreoretinal surgeons and that the identi-
fied evidence will aid standardisation of clinical practice,
with more effective management ultimately leading to
improved outcomes for patients following RRD surgery.
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